Cargando…
Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors
Current use of liquid biopsy is based on cell-free DNA (cfDNA) and the evaluation of mutations or methylation pattern. However, expressed RNA can capture mutations, changes in expression levels due to methylation, and provide information on cell of origin, growth, and proliferation status. We develo...
Autores principales: | Albitar, Maher, Zhang, Hong, Charifa, Ahmad, Ip, Andrew, Ma, Wanlong, McCloskey, James, Donato, Michele, Siegel, David, Waintraub, Stanley, Gutierrez, Martin, Pecora, Andrew, Goy, Andre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208940/ https://www.ncbi.nlm.nih.gov/pubmed/37251903 http://dx.doi.org/10.1016/j.heliyon.2023.e16261 |
Ejemplares similares
-
Predicting PD-L1 Status in Solid Tumors Using Transcriptomic Data and Artificial Intelligence Algorithms
por: Charifa, Ahmad, et al.
Publicado: (2024) -
Homologous Recombination Abnormalities Associated With BRCA1/2 Mutations as Predicted by Machine Learning of Targeted Next-Generation Sequencing Data
por: Albitar, Maher, et al.
Publicado: (2023) -
Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid Neoplasms
por: Ip, Andrew, et al.
Publicado: (2022) -
Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors
por: Albitar, Adam, et al.
Publicado: (2017) -
Predicting Prostate Biopsy Results Using a Panel of Plasma and Urine Biomarkers Combined in a Scoring System
por: Albitar, Maher, et al.
Publicado: (2016)